Pennant Group Stock
The Pennant Group, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Brent J. Guerisoli
- Employees
- 9,700
- Market cap
- $1.5 B
- IPO
- 01/10/2019
The Pennant Group, Inc. is a U.S.-based healthcare provider that delivers a diverse range of services through two core divisions. The segment "Home Health and Hospice Services" offers in-home clinical support, including nursing, speech, occupational, and physical therapy, as well as medical social work and home health…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Pennant Group stock: price history
1D
-0.9%
1W
+5.4%
1M
-1.4%
6M
+36.2%
YTD
+48.7%
1Y
+75.1%
2Y
+17.3%
5Y
+61.4%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~12% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Pennant Group
Analyst assessment of Pennant Group
PRICE TARGET LOW
US$40.00
CONSENSUS
US$44.50
MEDIAN
US$45.00
PRICE TARGET HIGH
US$48.00
0
STRONG BUY
6
BUY
1
HOLD
0
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 20/08/2026
Pennant Group stock metrics
P/E
44.54
P/B
4.06
EV/EBITDA
29.72
RETURN ON EQUITY
2.5%
NET MARGIN
3.0%
DEBT/EQUITY
1.38
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
95.0%
FLOAT SHARES
33,176,218
AVG. DAILY VOLUME (30D)
376,722
Insider transactions (SEC)
Steik Jason Paul
Guerisoli Brent
Cheney Kirk Sterling
Christensen Christopher R.
Nackel John G.
Institutional holders
Comparable stocks
Frequently asked questions about Pennant Group stock
What does Pennant Group do?
The Pennant Group, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Brent J. Guerisoli, the company employs around 9,700 people.
The IPO was on 01/10/2019; the stock trades on NASDAQ under the ticker PNTG.
What do analysts say about Pennant Group stock?
7 analysts rate the stock, the consensus is Buy (as of 20/08/2026).
The average price target is US$44.50, ranging from US$40.00 to US$48.00, with a median of US$45.00.
This is an external assessment, not a statement by Market Jury.
When does Pennant Group report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 12% stronger than usual.
Does Pennant Group pay a dividend?
No, Pennant Group currently does not pay a dividend.
Which stocks are comparable to Pennant Group?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Pennant Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Pennant Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.